Home › NCT03490929

CEUS for Blunt Abdominal Trauma in Children

Contrast Enhanced Ultrasonography for Blunt Abdominal Trauma Imaging in Children

Who can join

Ages 0 to 17 · All sexes

Inclusion Criteria:

1. Hemodynamically stable (defined as not needing massive transfusion protocol and not undergoing an emergent surgical procedure within the next hour)
2. History of or suspicion for blunt abdominal trauma
3. Abdominal CT ordered or obtained

Exclusion Criteria:

1. History of allergic reaction to Lumason, sulfur hexaflouride, sulfur hexafluoride lipid microsphere components, or other ingredients in Lumason (polyethylene glycol, distearoylphosphatidylcholine (DSPC), dipalmitoylphosphatidylglycerol sodium (DPPG-Na), palmitic acid)
2. Co-existing penetrating abdominal trauma
3. Known congenital or acquired heart disease

About the study

Children with blunt abdominal trauma often get a CT as the first line imaging to evaluate for intra-abdominal organ injury. CT scans have some downsides with regard to radiation exposure, costs, and need for transport. Contrast enhanced ultrasonography has recently shown some promise as a way to detect intra-abdominal organ injury and may be able to replace the need for conventional CT scanning, without the need for ionizing radiation and the ability to be performed at the bedside.

What is being tested

• Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON] (drug)
• contrast-enhanced ultrasound (device)

Sponsor: Children's Hospital of Philadelphia · Participants: 146 · Started: Jun 1, 2018

Contact the study team

• Aaron E Chen, MD · Phone: 2674260383
• Rachel Rempell, MD · Phone: 2155907041

Official record on ClinicalTrials.gov — NCT03490929

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.